Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test. 2009

Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
Immunoassay Center, 134th Street and 25th Avenue, Postal Code 6653, Cubanacan, Playa, Havana, Cuba. iqtsh3@cie.sld.cu

BACKGROUND Guthrie's bacterial inhibition assay was used in Cuba, since 1983. A decentralized program for the newborn screening of hyperphenylalaninemias started in the year 2000 using an ultramicro-fluorometric test (UMTEST PKU). METHODS A simple and rapid ultramicro-fluorometric test based on McCaman and Robin's method has been designed, developed and applied for the measurement of Phe in dried blood spots on filter paper. RESULTS The UMTEST PKU exhibited an acceptable precision and accuracy. Samples of 27528 newborns on filter paper Schleicher & Schuell 903 (S&S 903) from the National neonatal screening program were collected and analyzed, and the mean Phe concentration was 66.5 micromol/l. Our assay showed high Pearson and concordance correlations with 2 commercially available kits. A total of 521923 Cuban newborns were studied from the year 2000 to 2007 using the UMTEST PKU. Elevated blood phenylalanine levels were found in 1764 infants (0.34%) and no false negative were noted. Ten cases were diagnosed with phenylketonuria, all of them with an initial phenylalanine concentration over 360 micromol/l. CONCLUSIONS The analytical performance characteristics of our assay and its use in the National program have demonstrated its suitability for the neonatal screening of PKU.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D003462 Cuba An island in the Greater Antilles in the West Indies, south of Florida. With the adjacent islands it forms the Republic of Cuba. Its capital is Havana. It was discovered by Columbus on his first voyage in 1492 and conquered by Spain in 1511. It has a varied history under Spain, Great Britain, and the United States but has been independent since 1902. The name Cuba is said to be an Indian name of unknown origin but the language that gave the name is extinct, so the etymology is a conjecture. (From Webster's New Geographical Dictionary, 1988, p302 & Room, Brewer's Dictionary of Names, 1992, p132)
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015997 Neonatal Screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. Infant, Newborn, Screening,Newborn Infant Screening,Newborn Screening,Neonatal Screenings,Newborn Infant Screenings,Newborn Screenings,Screening, Neonatal,Screening, Newborn,Screening, Newborn Infant,Screenings, Neonatal,Screenings, Newborn,Screenings, Newborn Infant

Related Publications

Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
July 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
January 1982, Annals of clinical and laboratory science,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
March 1981, Journal de genetique humaine,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
May 1984, Pediatrics,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
September 1981, Clinica chimica acta; international journal of clinical chemistry,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
September 1982, American journal of human genetics,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
September 1991, BMJ (Clinical research ed.),
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
July 1962, Journal of the Philippine Medical Association,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
April 1990, Archives francaises de pediatrie,
Ernesto Carlos González, and Amarilys Frómeta, and Lesley del Río, and Elisa Castells, and Martha S Robaina, and Susana M García, and Tania Licourt, and Ana L Arteaga, and Laritza Martínez
January 1990, Revista chilena de pediatria,
Copied contents to your clipboard!